Suchergebnisse - "Koehler, Philipp"

PubPharm (7)

1

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies : 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Stemler, J. | Mellinghoff, S. | Khodamoradi, Y. | +20

2

Defining and managing COVID-19-associated pulmonary aspergillosis : the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

enthalten in: The Lancet. Infectious diseases | 2021

von Koehler, P. | Bassetti, M. | Chakrabarti, A. | +33

CommentIn: Lancet Infect Dis. 2021 Jun;21(6):767-769. - PMID 33662323

3

Antifungal prophylaxis and novel drugs in acute myeloid leukemia : the midostaurin and posaconazole dilemma

enthalten in: Annals of hematology | 2020

von Stemler, J. | Koehler, P. | Maurer, C. | +2

4

COVID-19 associated pulmonary aspergillosis

enthalten in: Mycoses | 2020

von Koehler, P. | Cornely, O. | Böttiger, B. | +11

5

Transdiaphragmatic Mucormycosis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Koehler, P. | Reimer, R. | Wahba, R. | +2

6

Matched-paired analysis of patients treated for invasive mucormycosis : standard treatment versus posaconazole new formulations (MoveOn)

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Salmanton-García, J. | Seidel, D. | Koehler, P. | +68

7

Our 2014 approach to mucormycosis

enthalten in: Mycoses | 2014

von Tacke, D. | Koehler, P. | Markiefka, B. | +1

1
[1]